Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New mRNA vaccine combo aims to stop lung cancer recurrence

NCT ID NCT06077760

Disease control Sponsor: Merck Sharp & Dohme LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 18, 2026 · Updated 10 times

Summary

This Phase 3 trial tests whether adding an experimental mRNA vaccine (V940) to standard immunotherapy (Keytruda) can prevent non-small cell lung cancer from coming back after surgery. About 868 people with stage II-IIIB lung cancer who have had their tumors completely removed will receive either the vaccine plus Keytruda or a placebo plus Keytruda. The study measures how long participants stay cancer-free and overall survival.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mRNA vaccine (V940) plus pembrolizumab (Keytruda)
What this could lead to
If it works, this could offer a new way to reduce the risk of lung cancer returning after surgery, potentially improving survival.
What could go wrong
This is an early Phase 3 trial, so results are not guaranteed. The vaccine may not prevent recurrence, and side effects from the combination therapy could be significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 868 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2023

Expected to finish

Dec 2035

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: The main inclusion criteria include but are not limited to the following: * Has undergone margin negative, completely resected non-small cell lung cancer (NSCLC), and has pathological Stage II, IIIA, IIIB (N2) squamous or nonsquamous tumor, node, metastasis (TNM) staging per American Joint Committee on Cancer (AJCC) Eighth Edition guidelines. * Has no evidence of disease before randomization. * Has received at least one dose of adjuvant treatment with standard of care platinum doublet chemotherapy. * No more than 24 weeks have elapsed between surgical resection of curative intent and the first dose of pembrolizumab. * Participants who are hepatitis B surface antigen (HBsAg) positive are eligible if they have received hepatitis B virus (HBV) antiviral therapy for at least 4 weeks and have undetectable HBV viral load prior to randomization. * Participants with history of hepatitis C virus (HCV) infection are eligible if HCV viral load is undetectable at screening. * Human immunodeficiency virus (HIV)-infected participants must have well controlled HIV on anti-retroviral therapy (ART). Exclusion Criteria: The main exclusion criteria include but are not limited to the following: * Diagnosis of small cell lung cancer (SCLC) or, for mixed tumors, presence of small cell elements, or has a neuroendocrine tumor with large cell components or a sarcomatoid carcinoma. * HIV-infected participants with a history of Kaposi's sarcoma and/or Multicentric Castleman's Disease. * Received prior neoadjuvant therapy for their current NSCLC diagnosis. * Received or is a candidate to receive radiotherapy for their current NSCLC diagnosis. * Received prior therapy with an anti-programmed cell death 1 protein (PD-1), anti-PD-ligand 1 (L1), or anti-PD-L2 agent, or with an agent directed to another stimulatory or coinhibitory T-cell receptor. * Received prior systemic anticancer therapy including investigational agents within 4 weeks before randomization. * Received a live or live-attenuated vaccine within 30 days before the first dose of study intervention. Administration of killed vaccines are allowed. * Has received an investigational agent or has used an investigational device within 4 weeks prior to study intervention administration. * Diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior to the first dose of study medication. * Known additional malignancy that is progressing or has required active treatment within the past 5 years. * Active autoimmune disease that has required systemic treatment in the past 2 years. Replacement therapy (eg, thyroxine, insulin, or physiologic corticosteroid) is allowed. * History of (noninfectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease. * Active infection requiring systemic therapy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Non-small cell lung cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Non-small cell lung cancer

Contacts and locations

Locations

  • A.O.R.N. Ospedale dei Colli - Monaldi V.-U.O.C Pneumologia Oncologica DH PNL ONC ( Site 1508)

    Naples, Napoli, 80131, Italy

  • AO Santa Maria della Misericordia-Oncology Department ( Site 1501)

    Perugia, Umbria, 06132, Italy

  • AOU Policlinico G. Rodolico - San Marco di Catania ( Site 1503)

    Catania, 95123, Italy

  • ASST Grande Ospedale Metropolitano Niguarda-Oncologia Falck ( Site 1511)

    Milan, Milano, 20162, Italy

  • AZORG Campus Aalst-Moorselbaan ( Site 0604)

    Aalst, Oost-Vlaanderen, 9300, Belgium

  • AdventHealth Orlando-AdventHealth Medical Group Hematology & Oncology at Orlandoc ( Site 0013)

    Orlando, Florida, 32804, United States

  • Akershus Universitetssykehus-Avdeling for lungesykdommer ( Site 1900)

    Lørenskog, Akershus, 1478, Norway

  • Alaska Oncology and Hematology ( Site 0039)

    Anchorage, Alaska, 99508, United States

  • Altru Health System ( Site 0040)

    Grand Forks, North Dakota, 58201, United States

  • Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 2101)

    Ankara, 06800, Turkey (Türkiye)

  • Antwerp University Hospital-Thoracic Oncology ( Site 0603)

    Edegem, Antwerpen, 2650, Belgium

  • Arké SMO S.A. de C.V. ( Site 3415)

    Distrito Federal, 6700, Mexico

  • Asan Medical Center-Department of Oncology ( Site 0405)

    Seoul, 05505, South Korea

  • Asklepios Klinik Gauting GmbH-Oncology ( Site 1209)

    Gauting, Bavaria, 82131, Germany

  • Assistance Publique Hôpitaux de Marseille - Hôpital Nord ( Site 1108)

    Marseille, Bouches-du-Rhone, 13915, France

  • Atlantic Health Morristown Medical Center ( Site 4018)

    Morristown, New Jersey, 07960, United States

  • Augusta-Kranken-Anstalt ( Site 1213)

    Bochum, North Rhine-Westphalia, 44791, Germany

  • Azienda Ospedaliera Santa Croce e Carle ( Site 1500)

    Cuneo, 12100, Italy

  • Azienda Ospedaliero Universitaria Maggiore della Carità ( Site 1502)

    Novara, 28100, Italy

  • Bacs-Kiskun Varmegyei Oktatokorhaz-Onkoradiologiai Kozpont ( Site 1401)

    Kecskemét, Bács-Kiskun county, 6000, Hungary

  • Baptist Cancer Center ( Site 4049)

    Memphis, Tennessee, 38120, United States

  • Beacon Cancer Care ( Site 0044)

    Post Falls, Idaho, 83854, United States

  • Bialostockie Centrum Onkologii ( Site 2005)

    Bialystok, Podlaskie Voivodeship, 15-027, Poland

  • Bradfordhill-Clinical Area ( Site 3103)

    Santiago, Region M. de Santiago, 8420383, Chile

  • Brüderkrankenhaus St. Josef Paderborn-Klinik für Hämatologie und Onkologie ( Site 1214)

    Paderborn, North Rhine-Westphalia, 33098, Germany

  • CARDINAL SANTOS MEDICAL CENTER-Research Room ( Site 3601)

    San Juan City, Metro Manila, National Capital Region, 1502, Philippines

  • CHU Bordeaux Haut-Leveque ( Site 1106)

    Pessac, Aquitaine, 33600, France

  • CHU GABRIEL MONTPIED ( Site 1105)

    Clermont-Ferrand, Puy-de-Dome, 63000, France

  • CIMCA ( Site 3300)

    San José, Provincia de San José, 10103, Costa Rica

  • CIO - Centro de Inmuno-Oncología de Occidente ( Site 3403)

    Guadalajara, Jalisco, 44630, Mexico

  • CRIO - CENTRO REGIONAL INTEGRADO DE ONCOLOGIA-Pesquisa Clínica ( Site 3007)

    Fortaleza, Ceará, 60336232, Brazil

  • CRO-IRCCS-Clinical Oncology ( Site 1510)

    Aviano, Friuli Venezia Giulia, 33081, Italy

  • Cancer and Hematology Centers of Western Michigan ( Site 4003)

    Grand Rapids, Michigan, 49503, United States

  • Centre Hospitalier Universitaire de Caen - Hôpital Côte de Nacre ( Site 1107)

    Caen, Calvados, 14000, France

  • Centre Hospitalier de l'Université de Montréal ( Site 0104)

    Montreal, Quebec, H2X 3E4, Canada

  • Centro de Investigacion Clinica de Oaxaca ( Site 3401)

    Oaxaca City, 68020, Mexico

  • Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 2003)

    Bydgoszcz, Kuyavian-Pomeranian Voivodeship, 85-796, Poland

  • Changhua Christian Hospital ( Site 0504)

    Changhua, 50006, Taiwan

  • Chungbuk National University Hospital-Internal medicine ( Site 0402)

    Cheongju-si, North Chungcheong, 28644, South Korea

  • Clinica Adventista Belgrano-Oncology ( Site 2901)

    Caba., Buenos Aires, C1430EGF, Argentina

  • Clinica Oncologica Especializada ( Site 3410)

    Mexico City, Mexico City, 3240, Mexico

  • Columbia University Irving Medical Center-CUIMC Herbert Irving Comprehensive Cancer Center Clinical ( Site 0054)

    New York, New York, 10032, United States

  • Cross Cancer Institute ( Site 0105)

    Edmonton, Alberta, T6G 1Z2, Canada

  • Drammen Sykehus, Vestre Viken HF ( Site 1903)

    Drammen, Buskerud, 3004, Norway

  • Edwards Comprehensive Cancer Center ( Site 4015)

    Huntington, West Virginia, 25701, United States

  • Ege Universitesi Hastanesi-Chest Diseases Department ( Site 2107)

    Bornova, İzmir, 35100, Turkey (Türkiye)

  • Errikos Dunant Hospital Center-Fourth Department of Oncology and Clinical Trials Unit ( Site 1301)

    Athens, Attica, 115 26, Greece

  • European Interbalkan Medical Center-Oncology Department ( Site 1302)

    Thessaloniki, 570 01, Greece

  • FALP-UIDO ( Site 3100)

    Santiago, Region M. de Santiago, 7500921, Chile

  • Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica ( Site 2202)

    Banská Bystrica, Banská Bystrica Region, 97517, Slovakia

  • Fakultni nemocnice Olomouc-Klinika plicnich nemoci a tuberkulozy ( Site 0701)

    Olomouc, 779 00, Czechia

  • Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1504)

    Milan, Lombardy, 20133, Italy

  • Fred Hutchinson Cancer Center ( Site 0002)

    Seattle, Washington, 98109, United States

  • Fundacion Estudios Clinicos-Oncology ( Site 2907)

    Rosario, Santa Fe Province, S2000DEJ, Argentina

  • Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 3013)

    São José do Rio Preto, São Paulo, 15090000, Brazil

  • Fundação Pio XII - Hospital de Câncer de Barretos ( Site 3004)

    Barretos, São Paulo, 14784400, Brazil

  • Gemeinschaftspraxis für Hämatologie und Onkologie Münster ( Site 1202)

    Münster, North Rhine-Westphalia, 48153, Germany

  • George Washington University Medical Faculty Associates ( Site 4064)

    Washington D.C., District of Columbia, 20037, United States

  • Good Samaritan Regional Medical Center-Samaritan Pastega Regional Cancer Center ( Site 0082)

    Corvallis, Oregon, 97330, United States

  • Greco-Hainsworth Centers for Research ( Site 4034)

    Chattanooga, Tennessee, 37421, United States

  • Grupo Ollin Care ( Site 3414)

    Pachuca, Hidalgo, 42000, Mexico

  • Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz - Pulmonologia Osztaly ( Site 1404)

    Győr, Győr-Moson-Sopron, 9024, Hungary

  • HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA-Medical Oncology ( Site 2403)

    Majadahonda, Madrid, Comunidad de, 28222, Spain

  • HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 2402)

    Pozuelo de Alarcón, Madrid, 28223, Spain

  • Hacettepe Universite Hastaneleri-oncology hospital ( Site 2100)

    Ankara, 06230, Turkey (Türkiye)

  • Harbour Cancer & Wellness ( Site 0301)

    Auckland, 1023, New Zealand

  • Helios Klinikum Emil von Behring Berlin-Zehlendorf-Lungenklinik Heckeshorn ( Site 1208)

    Berlin, 14165, Germany

  • Hirosaki University Hospital ( Site 3808)

    Hirosaki, Aomori, 036-8563, Japan

  • Hiroshima University Hospital ( Site 3804)

    Hiroshima, 734-8551, Japan

  • Hoag Memorial Hospital Presbyterian ( Site 4042)

    Newport Beach, California, 92663, United States

  • Hoag Memorial Hospital Presbyterian ( Site 4048)

    Newport Beach, California, 92663, United States

  • Hopitaux Universitaires Paris Centre-Hopital Cochin ( Site 1104)

    Paris, 75014, France

  • Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 2912)

    Ciudad Autonoma de Buenos Aires, Buenos Aires, C1199ABB, Argentina

  • Hospital Nossa Senhora da Conceição ( Site 3002)

    Porto Alegre, Rio Grande do Sul, 91350-200, Brazil

  • Hospital Pulau Pinang ( Site 3505)

    George Town, Pulau Pinang, 10450, Malaysia

  • Hospital Quirón Málaga ( Site 2405)

    Málaga, Malaga, 29004, Spain

  • Hospital Samaritano De Sao Paulo ( Site 3006)

    São Paulo, 01232-010, Brazil

  • Hospital Tengku Ampuan Afzan ( Site 3504)

    Kuantan, Pahang, 25100, Malaysia

  • Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 2400)

    Barcelona, 08035, Spain

  • Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Hematologia and Oncologia ( Site 3408)

    Monterrey, Nuevo León, 66460, Mexico

  • Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 2404)

    Seville, 41009, Spain

  • Hospital of Lithuanian University of Health Sciences Kauno klinikos-Pulmonology ( Site 1701)

    Kaunas, Kaunas County, 50161, Lithuania

  • Hyogo Cancer Center ( Site 3809)

    Akashi, Hyōgo, 673-8558, Japan

  • Hôpital Arnaud de Villeneuve - CHU Montpellier ( Site 1102)

    Montpellier, Herault, 34090, France

  • ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 3005)

    São Paulo, 01246-000, Brazil

  • ICIMED ( Site 3301)

    San José, 10108, Costa Rica

  • Icahn School of Medicine at Mount Sinai ( Site 0034)

    New York, New York, 10029, United States

  • Illinois Cancer Care ( Site 7003)

    Peoria, Illinois, 61615, United States

  • Inova Schar Cancer Institute ( Site 0003)

    Fairfax, Virginia, 22031, United States

  • Institut Català d'Oncologia - L'Hospitalet-Medical Oncology ( Site 2401)

    L'Hospitalet de Llobregat, Barcelona, 08908, Spain

  • Institut de Cancérologie de l'Ouest ( Site 1101)

    Angers, Maine-et-Loire, 49055, France

  • Instituto Alexander Fleming ( Site 2911)

    Ciudad Autónoma de Buenos Aires, Buenos Aires, C1426ANZ, Argentina

  • Instituto Nacional de Câncer - INCA ( Site 3000)

    Rio de Janeiro, 20230-130, Brazil

  • Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 2702)

    Porto, 4200-072, Portugal

  • Instituto Tumori Giovanni Paolo II-SSD Oncologia Medica per la Patologia Toracica ( Site 1507)

    Bari, Apulia, 70124, Italy

  • Instituto de Investigaciones Clínicas Mar del Plata ( Site 2908)

    Mar del Plata, Buenos Aires, B7600FZO, Argentina

  • Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 3003)

    Porto Alegre, Rio Grande do Sul, 90050-170, Brazil

  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0036)

    Hackensack, New Jersey, 07601, United States

  • Kanagawa Cancer Center ( Site 3801)

    Yokohama, Kanagawa, 241-8515, Japan

  • Kansai Medical University Hospital ( Site 3806)

    Hirakata, Osaka, 573-1191, Japan

  • Keimyung University Dongsan Hospital CRC room 1 ( Site 0407)

    Daegu, Taegu-Kwangyokshi, 42601, South Korea

  • Kindai University Hospital ( Site 3803)

    Sakai, Osaka, 590-0197, Japan

  • Klinikum Esslingen-Klinik für Kardiologie und Pneumologie ( Site 1201)

    Esslingen am Neckar, Baden-Wurttemberg, 73730, Germany

  • Klinikverbund Allgäu gGmbH ( Site 1205)

    Kempten (Allgäu), Bavaria, 87439, Germany

  • Krakowski Szpital Specjalistyczny im. Jana Pawła II-Oddział Kliniczny Chirurgii Klatki Piersiowej i ( Site 2011)

    Krakow, Lesser Poland Voivodeship, 30-002, Poland

  • LSU Health Baton Rouge North Clinic ( Site 4040)

    Baton Rouge, Louisiana, 70805, United States

  • Laura and Isaac Perlmutter Cancer Center ( Site 0010)

    New York, New York, 10016, United States

  • Liga Norte Riograndense Contra o Câncer ( Site 3001)

    Natal, Rio Grande do Norte, 59062-000, Brazil

  • Liv Hospital Ankara-Oncology ( Site 2104)

    Ankara, 06680, Turkey (Türkiye)

  • LungenClinic Grosshansdorf-Onkologie ( Site 1203)

    Großhansdorf, Schleswig-Holstein, 22927, Germany

  • Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 0700)

    Brno, Brno-mesto, 656 53, Czechia

  • Mayo Clinic Florida ( Site 4043)

    Jacksonville, Florida, 32224, United States

  • McGill University Health Centre ( Site 0100)

    Montreal, Quebec, H4A 3J1, Canada

  • Mediadvance Clinical ( Site 3404)

    Chihuahua City, 31203, Mexico

  • Medical University of South Carolina-Hollings Cancer Center ( Site 0050)

    Charleston, South Carolina, 29425, United States

  • Medipol Mega Universite Hastanesi-oncology ( Site 2105)

    Stanbul, Istanbul, 34214, Turkey (Türkiye)

  • Memorial Ankara Hastanesi-Medical Oncology ( Site 2103)

    Ankara, 06520, Turkey (Türkiye)

  • Memorial Sloan Kettering - Basking Ridge ( Site 4056)

    Basking Ridge, New Jersey, 07920, United States

  • Memorial Sloan Kettering - Bergen ( Site 4059)

    Montvale, New Jersey, 07645, United States

  • Memorial Sloan Kettering - Monmouth ( Site 4057)

    Middletown, New Jersey, 07748, United States

  • Memorial Sloan Kettering - Nassau ( Site 4060)

    Uniondale, New York, 11553, United States

  • Memorial Sloan Kettering - Westchester ( Site 4058)

    Harrison, New York, 10604, United States

  • Memorial Sloan Kettering Cancer Center ( Site 0029)

    New York, New York, 10065, United States

  • Memorial Sloan-Kettering Cancer Center at Commack ( Site 4055)

    Commack, New York, 11725, United States

  • Metro Davao Medical and Research Center ( Site 3602)

    Davao City, Davao Del Sur, 8000, Philippines

  • Miami Cancer Institute at Baptist Health, Inc. ( Site 4047)

    Miami, Florida, 33176, United States

  • Mid Florida Hematology and Oncology Center ( Site 0014)

    Orange City, Florida, 32763, United States

  • Moffitt Cancer Center ( Site 0078)

    Tampa, Florida, 33612, United States

  • Montefiore Medical Center- Montefiore Medical Park-Oncology ( Site 0080)

    The Bronx, New York, 10461, United States

  • NHO Revive Research Institute, LLC ( Site 4009)

    Lincoln, Nebraska, 68506, United States

  • Nagoya University Hospital ( Site 3810)

    Nagoya, Aichi-ken, 466-8560, Japan

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 2000)

    Warsaw, Masovian Voivodeship, 02-781, Poland

  • National Cancer Center Hospital East ( Site 3800)

    Kashiwa, Chiba, 277-8577, Japan

  • National Cancer Center-Lung Cancer Center ( Site 0403)

    Goyang-si, Kyonggi-do, 10408, South Korea

  • National Cancer Institute-Radiotherapy and Oncology ( Site 3506)

    Putrajaya, Kuala Lumpur, 62250, Malaysia

  • National Cheng Kung University Hospital-Clinical Trial Center ( Site 0505)

    Tainan, 704, Taiwan

  • National Taiwan University Cancer Center (NTUCC) ( Site 0500)

    Taipei City, Taipei, 106, Taiwan

  • National Taiwan University Hospital - Hsinchu branch ( Site 0501)

    Hsinchu, 300, Taiwan

  • National Taiwan University Hospital-Oncology ( Site 0506)

    Taipei, 10002, Taiwan

  • Nemocnica BORY a. s. ( Site 2205)

    Bratislava, Bratislava Region, 841 03, Slovakia

  • Nemocnice AGEL Ostrava - Vitkovice a.s.-Plicni odd ( Site 0702)

    Ostrava, Ostrava Mesto, 703 00, Czechia

  • New York Oncology Hematology, P.C. ( Site 4012)

    Albany, New York, 12206, United States

  • New Zealand Clinical Research (Christchurch) ( Site 0300)

    Christchurch, Canterbury, 8011, New Zealand

  • North Estonia Medical Centre Foundation-Chemotherapy ( Site 0901)

    Tallinn, Harju, 13419, Estonia

  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0012)

    Marietta, Georgia, 30060, United States

  • Nouvel Hôpital Civil (NHC)-Service de pneumologie ( Site 1100)

    Strasbourg, Alsace, 67091, France

  • Novant Health Oncology Specialists ( Site 4045)

    Winston-Salem, North Carolina, 27103, United States

  • Novant Health Weisiger Cancer Insititute ( Site 4052)

    Charlotte, North Carolina, 28204, United States

  • ONCOCENTRO APYS ( Site 3105)

    Viña del Mar, Valparaiso, 2520598, Chile

  • OSU Brain and Spine Hospital ( Site 0016)

    Columbus, Ohio, 43210, United States

  • Oaxaca Site Management Organization S.C. ( Site 3407)

    Oaxaca City, 68000, Mexico

  • Odense Universitetshospital ( Site 0800)

    Odense, Region Syddanmark, 5000, Denmark

  • Okayama University Hospital ( Site 3807)

    Okayama, 700-8558, Japan

  • One Clinical Research ( Site 0200)

    Nedlands, Western Australia, 6009, Australia

  • One Oncology - Tennessee Oncology ( Site 4019)

    Nashville, Tennessee, 37203, United States

  • Orlandi Oncologia-Oncology ( Site 3102)

    Santiago, Region M. de Santiago, 7500713, Chile

  • Oulun yliopistollinen sairaala-Oncology and Hematology ( Site 1003)

    Oulu, North Ostrobothnia, 90220, Finland

  • Our Lady of the Lake ( Site 4050)

    Baton Rouge, Louisiana, 70808, United States

  • P.O. "S. Maria della Misericordia" Azienda Sanitaria Univers-Oncology Department ( Site 1506)

    Udine, Friuli Venezia Giulia, 33100, Italy

  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island-Clinical Research Department ( Site 0095)

    Mineola, New York, 11501, United States

  • Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 0203)

    Melbourne, Victoria, 3000, Australia

  • Pontificia Universidad Catolica de Chile ( Site 3104)

    Santiago, Region M. de Santiago, 832000, Chile

  • Princess Margaret Cancer Centre ( Site 0102)

    Toronto, Ontario, M5G 2M9, Canada

  • Pécsi Tudományegyetem Klinikai Központ-Onkoterápiás Intézet ( Site 1402)

    Pécs, Baranya, 7624, Hungary

  • RIGA EAST UNIVERSITY HOSPITAL ,Oncology Centre of Latvia ( Site 1600)

    Riga, LV1079, Latvia

  • Reformatus Pulmonologiai Centrum ( Site 1405)

    Törökbálint, Pest County, 2045, Hungary

  • Rigshospitalet ( Site 0801)

    Copenhagen, Capital Region, 2100, Denmark

  • SCRI Oncology Partners ( Site 7001)

    Nashville, Tennessee, 37203, United States

  • SRH Wald-Klinikum Gera-Lungenkrebszentrum ( Site 1200)

    Gera, Thuringia, 07548, Germany

  • ST. LUKE'S MEDICAL CENTER ( Site 3606)

    Quezon City, National Capital Region, 1102, Philippines

  • Saint Elizabeth Healthcare ( Site 0092)

    Edgewood, Kentucky, 41017, United States

  • Samsung Medical Center ( Site 0401)

    Seoul, 06351, South Korea

  • Sanatorio Parque ( Site 2904)

    Rosario, Santa Fe Province, S2000DSV, Argentina

  • Sanford Cancer Center ( Site 0075)

    Sioux Falls, South Dakota, 57104, United States

  • Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0063)

    Fargo, North Dakota, 58102, United States

  • Sarawak General Hospital ( Site 3500)

    Kuching, Sarawak, 93586, Malaysia

  • Sendai Kousei Hospital ( Site 3805)

    Sendai, Miyagi, 981-0914, Japan

  • Seoul National University Bundang Hospital-Medical Oncology ( Site 0404)

    Seongnam, Kyonggi-do, 13620, South Korea

  • Seoul National University Hospital ( Site 0400)

    Seoul, 03080, South Korea

  • Somogy Varmegyei Kaposi Mor Oktato Korhaz -Onkologiai Kozpont ( Site 1407)

    Kaposvár, Somogy County, 7400, Hungary

  • Southeastern Regional Medical Center ( Site 0098)

    Newnan, Georgia, 30265, United States

  • St Vincent's Hospital-Oncology Clinical Trials ( Site 0202)

    Melbourne, Victoria, 3065, Australia

  • St. Joseph Hospital-The Center for Cancer Prevention and Treatment ( Site 0074)

    Orange, California, 92868, United States

  • St. Marianna University Hospital ( Site 3802)

    Kawasaki, Kanagawa, 216-8511, Japan

  • St. Vincent Frontier Cancer Center ( Site 0043)

    Billings, Montana, 59102, United States

  • Stavanger Universitetssykehus ( Site 1901)

    Stavanger, Rogaland, 4011, Norway

  • Stony Brook University-Cancer Center ( Site 0072)

    Stony Brook, New York, 11794, United States

  • Summa Health ( Site 4011)

    Akron, Ohio, 44304, United States

  • Swedish Medical Center-Swedish Cancer Institute ( Site 0088)

    Seattle, Washington, 98104, United States

  • TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2102)

    Istanbul, 34722, Turkey (Türkiye)

  • THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 1300)

    Athens, Attica, 115 27, Greece

  • Taichung Veterans General Hospital-Chest ( Site 0503)

    Taichung, 40705, Taiwan

  • Taipei Medical University Hospital ( Site 0502)

    Taipei, 110301, Taiwan

  • Tallaght University Hospital ( Site 3903)

    Dublin, D24 NR0A, Ireland

  • Tampereen yliopistollinen sairaala-Oncology ( Site 1001)

    Tampere, Pirkanmaa, 33520, Finland

  • Tartu University Hospital-Radiotherapy and oncology ( Site 0900)

    Tartu, Tartu, 50406, Estonia

  • The Blavatnik Family- Chelsea Medical Center at Mount Sinai ( Site 4053)

    New York, New York, 10011, United States

  • The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 0406)

    Suwon, Kyonggi-do, 16247, South Korea

  • The University of Arizona Cancer Center - North Campus ( Site 0071)

    Tucson, Arizona, 85719, United States

  • The University of Louisville, James Graham Brown Cancer Center ( Site 0037)

    Louisville, Kentucky, 40202, United States

  • Thomas Jefferson University - Clinical Research Institute ( Site 0006)

    Philadelphia, Pennsylvania, 19107, United States

  • Thompson Cancer Survival Center ( Site 0097)

    Knoxville, Tennessee, 37916, United States

  • Turku University Hospital-The Department of Pulmonary Medicine ( Site 1000)

    Turku, Southwest Finland, 20520, Finland

  • UCHealth Memorial Hospital-Heme Onc ( Site 0052)

    Colorado Springs, Colorado, 80909, United States

  • UCLA Clinical & Translational Research Center (CTRC) ( Site 0059)

    Los Angeles, California, 90095, United States

  • UT Southwestern Medical Center ( Site 0061)

    Dallas, Texas, 75390, United States

  • Unidad de Mastologia Avanzada de Chihuahua S.A de C.V ( Site 3402)

    Chihuahua City, 31123, Mexico

  • Unidade Local de Saude de Santa Maria - Hospital Pulido Valente ( Site 2703)

    Lisbon, Lisbon District, 1769-001, Portugal

  • Universitaetsklinikum Regensburg ( Site 1204)

    Regensburg, Bavaria, 93053, Germany

  • University Hospitals Cleveland Medical Center ( Site 0023)

    Cleveland, Ohio, 44106, United States

  • University Malaya Medical Centre ( Site 3502)

    Lembah Pantai, Kuala Lumpur, 59100, Malaysia

  • University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0030)

    Orange, California, 92868, United States

  • University of Cincinnati Medical Center-University of Cincinnati Cancer Center ( Site 0028)

    Cincinnati, Ohio, 45220, United States

  • University of Iowa-Holden Comprehensive Cancer Center ( Site 0062)

    Iowa City, Iowa, 52242, United States

  • University of Michigan Clinical Trials Office ( Site 0058)

    Ann Arbor, Michigan, 48109, United States

  • Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi ( Site 0602)

    Yvoir, Namur, 5530, Belgium

  • Univerzitná nemocnica Bratislava - Nemocnica Ružinov ( Site 2201)

    Bratislava, Bratislava Region, 826 06, Slovakia

  • Uniwersyteckie Centrum Kliniczne ( Site 2013)

    Gdansk, Pomeranian Voivodeship, 80-952, Poland

  • VITAZ ( Site 0600)

    Sint-Niklaas, Oost-Vlaanderen, 9100, Belgium

  • Vaasan Keskussairaala-Department of Clinical Oncology ( Site 1004)

    Vaasa, Pohjanmaa, 65130, Finland

  • Vilnius University Hospital Santaros Clinics Affiliate - National Cancer Center ( Site 1700)

    Vilnius, LT-08406, Lithuania

  • Virginia Cancer Specialists (VCS) ( Site 4004)

    Fairfax, Virginia, 22031, United States

  • Vseobecna fakultni nemocnice v Praze ( Site 0703)

    Prague, 12808, Czechia

  • Vychodoslovensky Onkologicky ustav a.s. ( Site 2200)

    Košice, Košice Region, 041 91, Slovakia

  • Warmińsko - Mazurskie Centrum Chorób Płuc w Olsztynie-Oddzial Onkologii z Pododdzialem Chemioterapii ( Site 2008)

    Olsztyn, Warmian-Masurian Voivodeship, 10-357, Poland

  • Wielkopolskie Centrum Pulmonologii i Torakochirurgii-Oddzial Onkologii Klinicznej z Pododdzialem Dz ( Site 2002)

    Poznan, Greater Poland Voivodeship, 60-569, Poland

  • William Osler Health System ( Site 0101)

    Brampton, Ontario, L6R 3J7, Canada

  • Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 2001)

    Przemyśl, Podkarpackie Voivodeship, 37-700, Poland

  • YUMA REGIONAL MEDICAL CENTER CANCER CENTER ( Site 0020)

    Yuma, Arizona, 85364, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.